90 related articles for article (PubMed ID: 27369862)
21. Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation.
Rockstroh A; Al-Ali HK; Lange T; Pönisch W; Krahl R; Cross M; Behre G; Niederwieser D; Pfrepper C
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2193-203. PubMed ID: 26129640
[TBL] [Abstract][Full Text] [Related]
22. Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.
Rogatko-Koroś M; Mika-Witkowska R; Bogunia-Kubik K; Wysoczańska B; Jaskuła E; Kościńska K; Nestorowicz K; Dziopa J; Szlendak U; Gwozdowicz S; Graczyk-Pol E; Lange A; Nowak J
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):63-71. PubMed ID: 27933342
[TBL] [Abstract][Full Text] [Related]
23. Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program.
Miyamoto T; Fukuda T; Nakashima M; Henzan T; Kusakabe S; Kobayashi N; Sugita J; Mori T; Kurokawa M; Mori SI
Biol Blood Marrow Transplant; 2017 Jun; 23(6):938-944. PubMed ID: 28219836
[TBL] [Abstract][Full Text] [Related]
24. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
25. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
Duan LN; Han HX; Liu J; Yan HM; Zhu L; Xue M; Ding L; Zhu PY; Wang HX; Ji SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):809-15. PubMed ID: 17708809
[TBL] [Abstract][Full Text] [Related]
26. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.
Passweg JR; Schanz U; Chalandon Y; Güngör T; Baldomero H; Heim D; Nair G; Medinger M; Masouridi-Levrat S; de Faveri GN; Tiercy JM;
Bone Marrow Transplant; 2015 Sep; 50(9):1201-5. PubMed ID: 26052916
[TBL] [Abstract][Full Text] [Related]
27. Role of Genetic Polymorphism of ALDH2 in Hematopoietic Stem Cell Transplantation.
Ugai T; Kanda Y; Morishima Y; Matsuo K
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1374-1380. PubMed ID: 28389253
[TBL] [Abstract][Full Text] [Related]
28. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
[TBL] [Abstract][Full Text] [Related]
29. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting.
Gustafsson A; Remberger M; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 May; 25(10):1059-65. PubMed ID: 10828866
[TBL] [Abstract][Full Text] [Related]
30. Unmanipulated bone marrow transplantation from one-HLA locus mismatched siblings carries high transplant-related mortality in Chinese patients.
Leung AY; Lie AK; Au WY; Hawkins BR; Kwong YL; Liang R
Haematologica; 2001 May; 86(5):518-22. PubMed ID: 11410416
[TBL] [Abstract][Full Text] [Related]
31. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation.
Kanda Y; Kanda J; Atsuta Y; Maeda Y; Ichinohe T; Ohashi K; Fukuda T; Miyamura K; Iida H; Mori T; Iwato K; Eto T; Kawa K; Morita S; Morishima Y
Br J Haematol; 2013 May; 161(4):566-77. PubMed ID: 23452319
[TBL] [Abstract][Full Text] [Related]
32. Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors.
Arrieta-Bolaños E; Mayor NP; Marsh SG; Madrigal JA; Apperley JF; Kirkland K; Mackinnon S; Marks DI; McQuaker G; Perry J; Potter MN; Russell NH; Thomson K; Shaw BE
Haematologica; 2016 Mar; 101(3):382-90. PubMed ID: 26611472
[TBL] [Abstract][Full Text] [Related]
33. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
[TBL] [Abstract][Full Text] [Related]
34. Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO).
Dini G; Cancedda R; Locatelli F; Bosi A; Bandini G; Alessandrino EP; Porta F; Uderzo C; Messina C; Fagioli F; Arcese W; Marenco P; Fanin R; Falda M; Soligo D; La Nasa G; Giardini C; Pession A; Scimè R; Di Bartolomeo P; Bruno B; Garbarino L; Lamparelli T; Giorgiani G; Lanino E; Manzitti C; Bacigalupo A;
Haematologica; 2001 May; 86(5):451-6. PubMed ID: 11410406
[TBL] [Abstract][Full Text] [Related]
35. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
[TBL] [Abstract][Full Text] [Related]
36. [The impact of HLA matching on outcome of single unit unrelated cord blood transplantation: a retrospective single center clinical analysis].
Sun G; Sun Z; Liu H; Zheng C; Tang B; Zhu X; Song K
Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):678-83. PubMed ID: 25152111
[TBL] [Abstract][Full Text] [Related]
37. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
[TBL] [Abstract][Full Text] [Related]
38. The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.
Dresse MF; Boogaerts M; Vermylen C; Noens L; Ferrant A; Schots R; Doyen C; Bron D; Berneman Z; Ferster A; Benoit Y; Demuynck H; Beguin Y
Haematologica; 1999 Jul; 84(7):637-42. PubMed ID: 10406907
[TBL] [Abstract][Full Text] [Related]
39. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
[TBL] [Abstract][Full Text] [Related]
40. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
